SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Dr. Juan Manuel Pérez - 28 April, 2026 0

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

Dr. Juan Manuel Pérez - 27 April, 2026 0

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Dr. Omar Tupayachi - 24 April, 2026 0

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: durability

SURTAVI at 5 Years

15/05 | SOLACI@Medtronic: Structural Heart Fellowship Program Support: Mastering TAVI Implant

Watch again our Webinar on TAVR in Low-Risk Patients

06/05 | SOLACI Webinar: TAVI in Low-Risk Patients

After 8-year Followup, Good News for the Self Expandable Valve

TAVR Long-Term Durability: from the Cath Lab to Real Life

Good News at 3 Years for “Valve-in-Valve”

Is TAVR Durable Beyond 5 Years?

New Study Confirms TAVR Durability at 5 Years

Últimas Noticias

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

Calcified Nodules and Their Treatment with Rotational Atherectomy

Noticias Institucionales

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

FAC Webinar | CTEPH: one disease, three strategies, one team,

Mourning the passing of Dr. Eugene Braunwald

Accesos